Valacyclovir hydrochloride

SKU: orb1309816

Description

Research Area

Cell Biology, Infectious Disease & Virology, Molecular Biology

Images & Validation

−

Key Properties

−

CAS Number	124832-27-5
MW	360.80
Purity	98.65%
Formula	C₁₃H₂₀N₆O₄·HCl
SMILES	Cl.CC(C)[C@H](N)C(=O)OCCOCn1cnc2c1nc(N)[nH]c2=O
Target	DNA/RNA Synthesis,Antibiotic,Antibacterial,HSV
Solubility	DMSO:20.4 mg/mL (56.54 mM);10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (5.54 mM)

Bioactivity

−

Target IC50	HSV1:2.9 μg/mL (IC50)
In Vivo	Valaciclovir is the L-valine ester of aciclovir, the absorption of which occurs in the intestinal lumen and is converted to the L-valine ester of aciclovir.Valaciclovir inhibits the uptake of dipeptide transporter protein substrates, e.g., cephalosporin. Read more...
In Vitro	In male CD rats, Valaciclovir was absorbed orally, efficiently metabolized and rapidly distributed.

Storage & Handling

−

Storage	Powder: -20°C for 3 years \| In solvent: -80°C for 1 year \| Shipping with blue ice/Shipping at ambient temperature.
Expiration Date	12 months from date of receipt.
Disclaimer	For research use only

Alternative Names

−

RNA Synthesis, RNASynthesis, Valaciclovir, Valaciclovir HCl, Valaciclovir hydrochloride, Valaciclovir Hydrochloride, Valacyclovir, Valacyclovir hydrochloride, Valacyclovir Hydrochloride, DNA Synthesis, DNA polymerase, DNASynthesis, Antibiotic, Herpes simplex virus, Inhibitor, HSV, inhibit

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at support@biorbyt.com.

Compound Identifiers

PubChem CID

135398741 ↗

Key Properties

−

No computed properties available.

Documents Download

Datasheet

Product Information

Download

Request a Document

Protocol Information

Find More Protocols